A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis
Clinical trial NCT04050865 · COMPLETED
Trial details
- NCT number
- NCT04050865
- Sponsor
- Ocular Therapeutix, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-05
- Primary completion
- 2020-02-28
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.